Loading the player.
Covaxin safe, immunogenic with no side effects, says Lancet
Medical peer-review journal Lancet has published the interim results for phase 2 trials of Bharat Biotech s COVID-19 vaccine, Covaxin, calling it safe, immunogenic with no serious side effects . The double-blind, randomised, multicentre, phase 2 clinical trial to evaluate the immunogenicity and safety of Covaxin (BBV152) in healthy adults and adolescents (aged 12-65 years) was carried out at nine hospitals in India.
Data breach can put up to $223 billion value of top-100 global brands at risk: Infosys
Data breach could put at risk up to $223 billion of brand value of the top 100 brands of the world, as per a joint cybersecurity and brand value impact report by Infosys and global brand consultancy firm Interbrand. The report examined the long-term impact of data breaches on value of the world s top brands across sectors.
Over 9.2 percent of the US population has been fully vaccinated with against the novel coronavirus. President Joe Biden said that the country would have enough Covid-19 vaccine doses for every adult American by the end of May.